Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab

Autor: Dekker, I., Leurs, C.E., Hagens, M.H.J., van Kempen, Z.L.E., Kleerekooper, I., Lissenberg-Witte, B.I., Barkhof, F., Uitdehaag, B.M.J., Balk, L.J., Wattjes, M.P., Killestein, J.
Zdroj: In Multiple Sclerosis and Related Disorders August 2019 33:82-87
Databáze: ScienceDirect